Yale researchers enroll first patient in study of heart-preserving molecule

July 24, 2012 By Karen N. Peart

(Medical Xpress) -- A 69-year-old man became the first patient enrolled and treated in an ongoing study at Yale School of Medicine of BB3, a molecule that promises to preserve heart muscle, promote healing and improve clinical outcomes in heart attack patients.

BB3 mimics the effects of hepatocyte growth factor, which appears to act as a modulator of . During a heart attack, the blood supply to part of the heart is interrupted, causing the surrounding to die and impair heart function. The amount of heart muscle that is lost and the nature of the repair process after the heart attack determine the eventual function of the damaged heart, and thus the quality of life of the patient.

Pre-clinical studies showed that following a heart attack, BB3 has the ability to not only prevent the death of affected , but to promote a healthy and adaptive repair process.

“We believe BB3 to be a promising therapy for the treatment of acute myocardial infarction,” said Dr. Frank Giordano, associate professor of medicine at Yale School of Medicine, and principal investigator at Yale-New Haven Hospital. “The trial will provide valuable data not only on the safety of BB3 in this population, but also whether this molecule can preserve , promote beneficial healing of the heart, and improve clinical outcomes in patients with acute myocardial infarction.

The Phase II double-blind, placebo-controlled multicenter trial is evaluating the safety and efficacy of BB3 in conjunction with routine care to improve heart function in patients who have experienced a first attack. The target enrollment is 80 patients who will be randomly assigned to receive BB3 or a placebo.

Patients between the ages of 21 and 80 who have had their first heart attack are potential candidates for this study, which is actively recruiting at Yale.

“While it is not known whether the first enrolled patient received BB3 or a placebo treatment, he is now home, doing well, and will receive careful follow up to evaluate his and response to treatment,” said Giordano.

Explore further: Stem cells from cord blood could help repair damaged heart muscle

More information: For more information or to enroll in the study, call 203-737-8320 or 203-737-2213.

Related Stories

Stem cells from cord blood could help repair damaged heart muscle

October 13, 2011
(Medical Xpress) -- New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks.

Helping the heart help itself: Research points to new use for stem cells

April 8, 2011
(PhysOrg.com) -- Human trials of stem cell therapy for post-heart attack patients have raised as many questions as they have answered -- because while the patients have tended to show some improvement in heart function, the ...

Recommended for you

Two studies support intensive blood pressure control for long-term health, quality of life

August 23, 2017
Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg - far below the standard guidelines of 140 mmHg - to reduce the risk of heart disease in high-risk patients with ...

Brain activity may be predictor of stress-related cardiovascular risk

August 23, 2017
The brain may have a distinctive activity pattern during stressful events that predicts bodily reactions, such as rises in blood pressure that increase risk for cardiovascular disease, according to new proof-of-concept research ...

Dramatic new studies into inflammation in the infarcted heart could lead to changes in therapy

August 23, 2017
A medical research collaborative has demonstrated that the response of the human heart to an infarction is very different than previously thought. The study, led by cardiologist Borja Ibáñez and published as two independent ...

'Shapeshifter' that regulates blood clotting is visually captured for the first time

August 23, 2017
We are normally born with a highly sophisticated array of molecules that act as "sentries," constantly scanning our bodies for injuries such as cuts and bruises. One such molecular sentry, known as von Willebrand factor (VWF), ...

New molecule may hold the key to triggering the regeneration and repair of damaged heart cells

August 21, 2017
New research has discovered a potential means to trigger damaged heart cells to self-heal. The discovery could lead to groundbreaking forms of treatment for heart diseases. For the first time, researchers have identified ...

Researchers investigate the potential of spider silk protein for engineering artificial heart

August 18, 2017
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.